Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 18 min ago
PreprintCC BY-NCbioRxiv

A Biophysical Platform for Electromechanical Stimulation of Engineered Cardiac Tissues

  1. 1Boston University

Abstract

Human engineered cardiac tissues (ECTs) provide an in vitro model for studying human cardiac physiology and drug responses, but their performance remains limited by culture systems that do not fully reproduce the heart's electrical and mechanical environment. Electrical stimulation (ES) and mechanical stimulation (MS) have each been used to improve ECT function. Their combination, referred to as electromechanical stimulation (ES+MS), can provide further benefits. However, ES+MS depends not only on the presence of both cues but also on how they are coordinated in time. Here, we developed an incubator-compatible biophysical platform that delivers ES and MS independently or in combination, with programmable control over timing, amplitude, frequency, duration, and waveform. Calibration and dynamic characterization demonstrated tissue-relevant strain delivery, rapid and repeatable motion, and minimal attenuation and timing lag at the designated frequency of 1.5 Hz. We then compared four 6 h conditioning regimens: unstimulated control, ES alone, unsynchronized ES+MS, and synchronized ES+MS. We hypothesized that the synchronized ES+MS group, in which electrical excitation was aligned with peak externally applied strain, would produce the greatest increase in contractile force. Consistent with this hypothesis, synchronized ES+MS increased normalized twitch force by approximately 44% on average, whereas the other groups showed no comparable improvement. Twitch-timing metrics did not exhibit coordinated enhancement after 6 h, suggesting that the force increase reflects an adaptive biomechanical response rather than broad tissue maturation. These findings identify ES-MS timing as an important design parameter for ECT conditioning.

Related

  1. Controlled electromechanical cell stimulation on-a-chip
    Andrea Pavesi, Giulia Adriani, Marco Rasponi +3
    Scientific ReportsPeer-reviewedCC BYFull text113 citedSystems & synthetic biologyHAL
  2. aaRSID, an engineered pyrrolysyl-tRNA synthetase platform for multi-probe proximity proteomics
    Z. Wang, T. Ruenkam, R. E. Schelling +8
    bioRxivPreprintAll rights reservedFull textCell biologybioRxiv
  3. Platelet-engineered AAV silencing of myocardial CD36 reprograms fatty acid metabolism to promote cardiac regeneration in male mice
    Ning Zhang, Mei Hua Ting, Siyuan Liu +10
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textGenetics & genomicsCrossref
  4. Engineered mRNA nanostructures expand the design space of mRNA therapeutics through programmable protein expression and immune stimulation
    M. Knappenberger, S. Henry, A. Kikla +7
    bioRxivPreprintCC BY-NC-NDFull textSystems & synthetic biologybioRxiv
  5. Stimulatrix: An open-source automated platform for high-throughput functional characterization of engineered contractile tissues
    M. Winkelbauer, J. Bast, E. S. Casalino +10
    bioRxivPreprintCC BYFull textSystems & synthetic biologybioRxiv
BibTeX
@misc{hu2026biophysical,
  title = {{A Biophysical Platform for Electromechanical Stimulation of Engineered Cardiac Tissues}},
  author = {R. Hu and C. E. Varela and M. C. Karakan and F. Sanchez and B. Wolking and C. S. Chen and T. G. Bifano},
  howpublished = {bioRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.31.747584},
  url = {https://www.biorxiv.org/content/10.64898/2026.08.31.747584v1},
  note = {CC BY-NC},
}
RIS
TY  - UNPB
TI  - A Biophysical Platform for Electromechanical Stimulation of Engineered Cardiac Tissues
AU  - R. Hu
AU  - C. E. Varela
AU  - M. C. Karakan
AU  - F. Sanchez
AU  - B. Wolking
AU  - C. S. Chen
AU  - T. G. Bifano
PY  - 2026
DA  - 2026/08/31
PB  - bioRxiv
DO  - 10.64898/2026.08.31.747584
UR  - https://www.biorxiv.org/content/10.64898/2026.08.31.747584v1
AB  - Human engineered cardiac tissues (ECTs) provide an in vitro model for studying human cardiac physiology and drug responses, but their performance remains limited by culture systems that do not fully reproduce the heart's electrical and mechanical environment. Electrical stimulation (ES) and mechanical stimulation (MS) have each been used to improve ECT function. Their combination, referred to as electromechanical stimulation (ES+MS), can provide further benefits. However, ES+MS depends not only on the presence of both cues but also on how they are coordinated in time. Here, we developed an incubator-compatible biophysical platform that delivers ES and MS independently or in combination, with programmable control over timing, amplitude, frequency, duration, and waveform. Calibration and dynamic characterization demonstrated tissue-relevant strain delivery, rapid and repeatable motion, and minimal attenuation and timing lag at the designated frequency of 1.5 Hz. We then compared four 6 h conditioning regimens: unstimulated control, ES alone, unsynchronized ES+MS, and synchronized ES+MS. We hypothesized that the synchronized ES+MS group, in which electrical excitation was aligned with peak externally applied strain, would produce the greatest increase in contractile force. Consistent with this hypothesis, synchronized ES+MS increased normalized twitch force by approximately 44% on average, whereas the other groups showed no comparable improvement. Twitch-timing metrics did not exhibit coordinated enhancement after 6 h, suggesting that the force increase reflects an adaptive biomechanical response rather than broad tissue maturation. These findings identify ES-MS timing as an important design parameter for ECT conditioning.
ER  -